with glucocorticoid (hyperglycaemic) activity oppose the blood glucose lowering effects of the antidiabetics
. Significant hyperglycaemia has been seen with systemic corticosteroids, and in cases with inhaled corticosteroids
or high- potency topical corticosteroids
It would seem prudent to increase blood glucose monitoring when a corticosteroid is started and adjust the antidiabetic treatment accordingly. Routine monitoring of local corticosteroids
appears over-cautious, but be aware that isolated cases of hyperglycaemia have been reported.